Cleerly is devoted to generating predictive and diagnostic software products using machine learning on radiological image data. The machine learning strategy licensed from Cornell can make connections and inferences about health that a human brain would miss. Their first round of products will be aimed at assessing heart health and will provide a user friendly platform for doctors and patients to learn about their heart by exploiting the connections made using the machine learning strategy. The technology was developed in the Dalio Institute for Cardiovascular Imaging.
